Login / Signup
Letter: vedolizumab for autoimmune liver disease associated inflammatory bowel disease.
Polychronis Pavlidis
J Graham
S Gulati
P Dubois
M Heneghan
D Joshi
B Hayee
Published in:
Alimentary pharmacology & therapeutics (2019)
Keyphrases
</>
ulcerative colitis
patients with inflammatory bowel disease
multiple sclerosis
drug induced